The medicines decisions made at the NENC Clinical Effectiveness and Governance (CEG) Subcommittee May 2026 meeting can now be found at: https://ntag.nhs.uk/meetings/decision-summaries/
This includes the recommendations made by NTAG at its May 2026 meeting and NICE Technology appraisals from the 1st February 2026 to 31st March 2026.
The following new guidelines were approved and can be found at:
- NENC Guideline for the Recognition and Management of Faltering Growth in Infants and Young Children – https://ntag.nhs.uk/wp-content/uploads/2026/06/NENC-ICB-Faltering-Growth-Guideline-approved-May-2026.pdf
- NENC Guidance for Gynaecological Problems in Primary Care – awaiting final versions for publication on NTAG website.
The following reviewed guidelines were approved and can be found at:
- NENC Penicillin Allergy Assessment primary care for adult patients – no updates made
The following reviewed and updated shared care guidelines were approved and can be found at:
- NENC Shared Care Protocol – Guanfacine for patients within adult services – technical updates as per change table on front page and May 2026 CEG decision summary. /https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Guanfacine for patients within children’s services – technical updates as per change table on front page and May 2026 CEG decision summary. /https://ntag.nhs.uk/shared-care-guidelines/
- NENC Shared Care Protocol – Lithium for patients within adult services – addition of cluster headache as an indication plus technical updates as per change table on front page and May 2026 CEG decision summary. https://ntag.nhs.uk/shared-care-guidelines/
The following were also approved:
- NENC Deciding Right Guidance and documentation